At the age of 7, columnist Anna Jeter was already a pro at explaining heart catheterizations and answering other health ...
Tectonic Therapeutic is reviving relaxin biology with TX45, targeting Group 2 Pulmonary Hypertension with HFpEF. Check out ...
New findings reveal pulmonary arterial hypertension may affect the brain early. Learn how inflammation and cognitive decline ...
Now that her health has improved, columnist Jolie Lizana's greatest challenge is learning how to live fully within the limits ...
Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) Annual Scientific Session and Expo in New Orleans, March 28 to 30. The ...
Objective Women of reproductive age (WRA) in low-income and middle-income countries (LMICs) bear a disproportionate burden of ...
Abstract: Pulmonary hypertension (PH) is a fatal pulmonary vascular disease. The standard diagnosis of PH heavily relies on an invasive technique, i.e., right heart catheterization, which leads to a ...
Pulmonary hypertension is a condition where specialist input is essential, yet the day-to-day management of many patients takes place in local hospitals, usually in general respiratory clinics, far ...
Primary aldosteronism (PA) is a distinct cause of low-renin hypertension (LRH), characterized by inappropriate aldosterone production. We investigated the distinction between LRH and PA by leveraging ...
Pulmonary hypertension (PH) is a progressive disease marked by pulmonary arterial remodeling and right ventricular dysfunction. The molecular mechanisms driving this remodeling, particularly ECM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results